6-month Efficacy and Safety of Synolis VA 80/160 in Hip Osteoarthritis
ConditionOsteoarthritis, Hip
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorAptissen SA
About this trial
Multicenter, independent study of Synolis VA 80/160 over a period of 6 months
Eligibility criteria
Qualifiers
Patient over 18 years of age,
Treated hip pain: Oxford score ≥ 21/60,
Kellgren-Lawrence positive X-ray stage: II - III (inclusion radiograph dated no more than 6 months before the inclusion visit),
Symptoms related to osteoarthritis of the hip for at least 2 months,
Disqualifiers
Pregnancy,
Participation in another clinical trial,
Skin lesion near the injection site,
Recent or old infection of the affected joint,
Trial design
Treatments tested in this trial
- SYNOLIS VA 80/160
Treatment groups
70 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov